Author： Rovira J.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.14, Iss.1, 1998-07, pp. : 135-137
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Pros and Cons of a Single Euro-Price For Drugs
By Towse A.
PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. :
Access to resources
Recommend
The pros and cons of Rx-to-OTC switching of drugs in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Pros and Cons for the Development of New Antiepileptic Drugs
By Bialer M.
CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. :
Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. :